Rick Bienkowski – Cantor Fitzgerald

Cantor Fitzgerald

A Cantor Fitzgerald analyst with 11 tracked ratings across 8 distinct tickers has a 0.1 out of 5 stars track record and a 35.3% success rate on the captured sample.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

10 months ago

2025-08-19 00:00:00+00

Track record

Aggregated

No track record data

Bullish: 3
Hold: 0
Bearish: 0

Aggregated

35% success rate

Bullish: 4
Hold: 2
Bearish: 0

Aggregated

Not available

Bullish: 3
Hold: 0
Bearish: 0

Recent ratings

Ticker	Date	Rating	Price target	Source
BEAM	2025-08-19	buy	-	Aggregated
NTLA	2025-05-29	buy	$65.00	Aggregated
LEGN	2025-05-14	buy	$55.00	Aggregated
LEGNLEGEND BIOTECH CORP - ADR	2025-05-14	unknown	$55.00	Aggregated
BEAM	2025-03-12	buy	-	Aggregated
BEAM	2025-01-29	buy	-	Aggregated
NTLA	2024-06-24	buy	$65.00	Aggregated
NTLAINTELLIA THERAPEUTICS INC	2024-06-24	unknown	$65.00	Aggregated
BEAM	2023-10-17	buy	$32.00	Aggregated
BEAMBEAM THERAPEUTICS INC	2023-10-17	unknown	$32.00	Aggregated
EDIT	2023-09-13	buy	$14.00	Aggregated
EDITEDITAS MEDICINE INC	2023-09-13	unknown	$14.00	Aggregated
VERV	2023-09-13	hold	$22.00	Aggregated
VERVVERVE THERAPEUTICS INC	2023-09-13	hold	$22.00	Aggregated

Tickers covered(10)

Ticker	Ratings	Last rating	Sources
BEAM	6	2025-08-19	Aggregated
NTLA	3	2025-05-29	Aggregated
LEGN	3	2025-05-14	Aggregated
LEGNLEGEND BIOTECH CORP - ADR	1	2025-05-14	Aggregated
NTLAINTELLIA THERAPEUTICS INC	1	2024-06-24	Aggregated
BEAMBEAM THERAPEUTICS INC	1	2023-10-17	Aggregated
EDIT	2	2023-09-13	Aggregated
EDITEDITAS MEDICINE INC	1	2023-09-13	Aggregated
VERV	1	2023-09-13	Aggregated
VERVVERVE THERAPEUTICS INC	1	2023-09-13	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.